These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2837844)

  • 1. Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation.
    Roodman ST; Miller LW; Tsai CC
    Transplantation; 1988 Jun; 45(6):1050-6. PubMed ID: 2837844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and cell surface markers in prediction of cardiac allograft rejection.
    Chang DM; Ding YA; Kuo SY; Chang ML; Wei J
    Immunol Invest; 1996; 25(1-2):13-21. PubMed ID: 8675230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocyte activation in acute severe asthma.
    Corrigan CJ; Hartnell A; Kay AB
    Lancet; 1988 May; 1(8595):1129-32. PubMed ID: 2896958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
    Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K
    Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating activated T lymphocytes in autoeczematization.
    Kasteler JS; Petersen MJ; Vance JE; Zone JJ
    Arch Dermatol; 1992 Jun; 128(6):795-8. PubMed ID: 1599265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus erythematosus.
    Volk HD; Kopp J; Körner IJ; Jahn S; Grunow R; Barthelmes H; Fiebig H
    Scand J Immunol; 1986 Jul; 24(1):109-14. PubMed ID: 3014641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminating rejection from CMV infection in renal allograft recipients using flow cytometry.
    Siegel DL; Fox I; Dafoe DC; Power M; Asplund M; Zellers L; Barker CF; Prystowsky MB
    Clin Immunol Immunopathol; 1989 May; 51(2):157-71. PubMed ID: 2539282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
    Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
    Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte subsets and activation antigens in a reference population: a flow cytometric study using single and double antibody staining.
    Schuerch C; Fleetwood M; Glidewell O
    Immunol Invest; 1987 Jun; 16(4):345-60. PubMed ID: 2828230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.
    Odum N; Morling N; Platz P; Hofmann B; Ryder LP; Heilmann C; Pedersen FK; Nielsen LP; Friis J; Svejgaard A
    Ann Rheum Dis; 1987 Nov; 46(11):846-52. PubMed ID: 2827591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy.
    Saito S; Nishikawa K; Morii T; Narita N; Enomoto M; Ichijo M
    Immunology; 1992 Apr; 75(4):710-2. PubMed ID: 1592443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
    Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
    Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-lymphocyte subsets in gut and blood of liver transplant recipients with and without cytomegalovirus gastroenteritis.
    Van Thiel DH; Chen KN; Chien MC; Dindzans VJ; Gavaler JS; Whiteside TL
    Dig Dis Sci; 1989 Nov; 34(11):1751-7. PubMed ID: 2555122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes.
    Davidson BL; Faust J; Pessano S; Daniele RP; Rovera G
    J Clin Invest; 1985 Jul; 76(1):60-5. PubMed ID: 3926821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
    Konishi K; Moller DR; Saltini C; Kirby M; Crystal RG
    J Clin Invest; 1988 Sep; 82(3):775-81. PubMed ID: 3138285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.
    Norose K; Yano A
    Br J Ophthalmol; 1996 Nov; 80(11):1002-8. PubMed ID: 8976730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.